Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin (2010)
- Authors:
- Cerda, Álvaro
- Genvigir, Fabiana Dalla Vecchia
- Arazi, Simone Sorkin
- Hirata, Mario Hiroyuki
- Dórea, Egidio Lima
- Bernik, Marcia Martins Silveira
- Bertolami, Marcelo Chiara - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Faludi, Andre Arpad - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Hirata, Rosario Dominguez Crespo
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- DOI: 10.1016/j.cca.2010.01.002
- Subjects: FARMACOGENÉTICA; POLIMORFISMO; COLESTEROL
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinica Chimica Acta
- ISSN: 0009-8981
- Volume/Número/Paginação/Ano: v. 411, n. 9-10, p. 631-637, 2010
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CERDA, Álvaro et al. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin. Clinica Chimica Acta, v. 411, n. 9-10, p. 631-637, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2010.01.002. Acesso em: 20 abr. 2024. -
APA
Cerda, Á., Genvigir, F. D. V., Arazi, S. S., Hirata, M. H., Dórea, E. L., Bernik, M. M. S., et al. (2010). Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin. Clinica Chimica Acta, 411( 9-10), 631-637. doi:10.1016/j.cca.2010.01.002 -
NLM
Cerda Á, Genvigir FDV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Hirata RDC. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin [Internet]. Clinica Chimica Acta. 2010 ; 411( 9-10): 631-637.[citado 2024 abr. 20 ] Available from: https://doi.org/10.1016/j.cca.2010.01.002 -
Vancouver
Cerda Á, Genvigir FDV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Hirata RDC. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin [Internet]. Clinica Chimica Acta. 2010 ; 411( 9-10): 631-637.[citado 2024 abr. 20 ] Available from: https://doi.org/10.1016/j.cca.2010.01.002 - Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
- Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
Informações sobre o DOI: 10.1016/j.cca.2010.01.002 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
